Fisetin

Tonight, ask yourself why you're taking fisetin. If the answer is "longevity" or "anti-aging," that benefit has never been shown in a single human.

Its whole reputation comes from a study in old mice. The human trials so far measured safety and blood levels, not whether anyone actually got healthier. You can stop and keep your money.

Takes less than 2 minutes. No equipment needed.

The Protocol

There's no proven effective human dose, because there's no proven human benefit. This is what's actually been studied, not a promise that it works.

Approach	Dose	Schedule	Form
Senolytic "pulse" (research protocol)	~20 mg per kg bodyweight/day (roughly 1,400 mg/day for a 155 lb adult)	2 days in a row, occasionally repeated	Standard fisetin (paired with a prescription drug in trials)
Daily metabolic dosing (exercise trials)	200 mg/day (about one small capsule)	Every day	Standard capsule
If you trial it at all	Use the pulse schedule the science is based on, not a daily habit	Intermittent, with a fatty meal	Cheap standard form

Which form?

Standard powder/capsule

Cheapest · poorly absorbed

The only form with any human safety track record. Take with fat.

£

Hydrogel "enhanced"

Higher blood levels · PK only

Raises plasma levels on paper. No proof of a better result.

££

Liposomal / nano

Unknown in humans

Marketing. No outcome data versus the cheap form.

£££

Absorption: Fisetin is fat-soluble and poorly absorbed, so take it with a fatty meal. Don't over-invest in "enhanced" forms. A higher absorption graph is not a benefit you can feel.

Safety & Interactions

Safety is the part of the fisetin story that actually holds up in humans. Across every human pilot it was well tolerated, with no excess side effects versus placebo.

Statins, blood thinners, immune-suppressing drugs

Flavonols like fisetin can affect the same liver pathways these drugs use. This is a class concern carried over from quercetin, not measured for fisetin directly. If you take these, check with your prescriber before high-dose pulses.

Dasatinib (prescription)

Some senolytic research pairs fisetin with this prescription cancer drug. That's a clinician-supervised regimen, not a DIY supplement stack.

Pregnancy & breastfeeding

No human safety data. Avoid.

No tolerable upper limit has been set in humans, and there are no fisetin-specific human drug-interaction studies. Mild stomach upset is possible at high pulse doses; take with food.

Conviction

LOW

The fame rests on one aged-mouse study. The human record is pharmacokinetics, safety, and biomarkers, plus one real clinical trial (knee osteoarthritis) that came back negative.

What would change this verdict?

An independent, placebo-controlled trial of at least 150 older adults (60+), using the intermittent pulse schedule for 6+ months, with a real functional endpoint (walking speed, getting out of a chair, or a frailty score) showing a clear benefit, would move human-efficacy from "none" to "moderate." A trial showing fewer falls, less disability, or longer survival would be the first real test of the longevity claim. Moving a single lab marker would not be enough, because the osteoarthritis trial already showed markers can shift without anyone feeling better.

Worth Your Money?

Weekly costRoughly £3.50–£9 per week (£15–£40 per month, depending on dose and form).

Worth it ifYou're experimenting with full awareness that no human benefit has been shown, and you accept you're paying for a hypothesis.

Lower priority ifYour sleep, protein intake, or training basics aren't dialed in. Your next £30 buys far more health there than it does on an unproven longevity capsule.

Skip

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week, with the actual evidence. Free.

Join The Verdict — free

Claims vs Evidence — See What the Research Found

What People Claim

"The most potent natural senolytic. Clears the aging 'zombie' cells that drive aging, rolls back biological age, and extends healthspan and lifespan."

Fisetin rides the same wave as the Mayo Clinic senolytic research and gets stacked into longevity protocols beside NMN, resveratrol, spermidine, and quercetin. As a hypothesis, fair enough. The question is whether any of it has been shown in people.

What the Evidence Actually Shows

Claim	Strength	What the data says
Extends lifespan / healthspan	NONE (HUMAN)	Mouse lifespan extended; zero human outcome data.
Clears senescent cells / lowers inflammation signals	EMERGING	One small human study saw fewer senescent immune cells. Biomarker only.
Knee osteoarthritis (pain / function)	NULL	A placebo-controlled trial found no benefit on pain, function, cartilage, or gait.
Metabolic / inflammation markers	LOW	Marker shifts in obese men, but fisetin was added to 12 weeks of training, so it can't be separated from exercise.
Vascular / artery function	NONE (HUMAN)	Improved in old mice. Human trial ongoing, no results.
Cancer / brain / kidney protection	NONE (HUMAN)	Cell and animal work only.
Safety / tolerability	MODERATE	Consistently well tolerated, no excess side effects vs placebo.
Established human pharmacokinetics	MODERATE	Blood levels and metabolism have been characterized in people.

What would change this: an independent, powered, placebo-controlled human trial with a real functional or clinical endpoint, not just a lab marker.

The Full Picture — Mechanism, Debate & Nuance

How It Works

As cells age, some enter a state called senescence: they stop dividing but stay alive and pump out an inflammatory mix that drives a lot of age-related decline. In cells and mice, fisetin pushes some of these worn-out cells to die, quiets that inflammation, and acts as an antioxidant.

Here's the catch, and it's the whole story. Every step of that chain is established in cell cultures and rodents. The human step, whether occasionally clearing these cells actually makes a person healthier, stronger, or longer-lived, has not been demonstrated. The famous 2018 study crowned fisetin the most potent senolytic of a flavonoid panel in mice. That's a mouse result wearing a longevity halo.

The Debate

Mouse lifespan vs human silence

Yousefzadeh 2018
Fisetin extended healthspan and lifespan in aged mice.

vs

Knee OA trial 2025
No benefit on pain, function, cartilage, or gait in humans.

The mouse lifespan signal has not translated to any measured human outcome. The one human trial with a hard endpoint missed.

Marker movement vs feeling better

Hambright 2024
Fisetin lowered senescent-cell and inflammation markers in humans.

vs

OA trial 2025
That marker movement did not produce any clinical benefit.

Moving a lab number is not the same as improving a symptom. This is the recurring trap of the whole longevity-supplement category.

Honest Limitations

The lifespan claim is a mouse study

Lab: aged mice cleared of senescent cells lived longer. Reality: no human has been shown to gain healthspan, function, or years. Far more conservative than the marketing implies.

Dosing schedule mismatch

Lab: the effect rests on occasional high-dose pulses. Reality: consumers take a daily low dose. People aren't even taking it the way the mouse data suggests.

Bioavailability and product variability

Lab: controlled formulations, measured blood levels. Reality: standard fisetin is poorly absorbed and supplement content varies, with no outcome standard to anchor a dose to.

The Nuance

No human population has shown a clinical benefit. The two 2026 trials that exist studied men with obesity, and even there fisetin was inseparable from a structured exercise program. The food angle: strawberries are the richest dietary source of fisetin, but food delivers far below the studied doses, so "eat more strawberries for longevity" is its own overreach.

What doesn't work

"Fisetin extends your lifespan." That's mouse data. No human lifespan or mortality evidence exists.
"Take it daily for longevity." The mechanism implies occasional pulses, and neither schedule has shown a human benefit.
"Enhanced-absorption fisetin works better." Those forms prove higher blood levels only, never a better result.
"Fisetin treats arthritis." The one human trial that tested this was negative.

Sources

Yousefzadeh MJ, et al. (2018). Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. Aged-mouse senolytic screen; fisetin most potent of panel; extended mouse lifespan. Preclinical (mouse). PMID 30279143.
Tavenier J, et al. (2024). Pilot trial of fisetin pharmacokinetics and safety in healthy volunteers and older multimorbid patients. Intermittent dosing; well tolerated; safety/PK only.
Enhanced bioavailability of a hybrid-hydrogel fisetin formulation in healthy individuals (2022). Randomised double-blind crossover; raised plasma exposure; pharmacokinetics only. PMID 36304817.
Knee osteoarthritis fisetin trial report (2025). Placebo-controlled; safe; no benefit on pain, function, cartilage, or gait.
Hambright WS, et al. (2024). Reported reduced senescent immune cells and inflammation markers in humans; biomarker-level, preliminary.
Interval training plus fisetin on adipokines in men with obesity (2026). N=60; effect confounded with 12-week exercise. PMID 41683255.
Fisetin plus interval training on Maresin-1 and inflammatory markers in men with obesity (2026). N=44; confounded with training. PMID 42218768.
Intermittent fisetin improves arterial function in old mice (2024). Preclinical (mouse). PMID 38062873.

Fisetin made old mice live longer. In people, there's no proof it does anything you'd feel.